生物可吸收聚合物市场规模、份额和成长分析（按材料类型、应用和地区）- 产业预测 2025-2032

2023 年全球生物可吸收聚合物市场规模价值 38 亿美元，预计将从 2024 年的 41.9 亿美元成长到 2032 年的 91.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.3%。

预计全球生物可吸收聚合物市场将显着成长，这得益于消费者健康意识的增强、医疗保健基础设施的加强以及外科手术的增加（每年进行 3.1 亿例大型手术）。这些聚合物越来越多地被应用于缝合锚和干涉螺丝等整形外科植入中，因此无需进行修復手术，同时提高了患者的舒适度。推动该行业发展的关键趋势包括微创手术的趋势以及对先进医疗设备的日益增长的需求，尤其是药物传输和组织工程。最近的创新，例如 Ashland 对其在爱尔兰的工厂的扩建和 Bioretec 经 FDA核准的RemeOs™ 创伤螺钉，反映了在提高生物分解性和生物相容性方面不断取得的进步。监管支持和不断增加的医疗保健投资也推动了该市场的成长，满足了重大的临床需求。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

生物可吸收聚合物市场规模（按材料类型和复合年增长率） (2025-2032)

• 市场概况
• 聚乳酸
• 聚羟基烷酯
• 淀粉混合物
• Polybutylene Succinate
• 胺甲酸乙酯

生物可吸收聚合物市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 包装
• 农业
• 医疗
• 消费品
• 纤维
• 其他的

生物可吸收聚合物市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Corbion NV（Netherlands）
• Evonik Industries AG（Germany）
• Foster Corporation（United States）
• KLS Martin Group（Germany）
• DSM Biomedical（United States）
• Ashland Global Holdings Inc.（United States）
• Zeus Company LLC（United States）
• Seqens（France）
• REVA Medical LLC（United States）
• Poly-Med Incorporated（United States）
• Bezwada Biomedical LLC（United States）
• Nomisma Healthcare Pvt. Ltd.（India）
• BMG Incorporated（United States）
• Polysciences Inc.（United States）
• Huizhou Foryou Medical Devices Co. Ltd.（China）
• Musashino Chemical Laboratory Ltd.（Japan）
• Henan Xinghan Biotechnology Co. Ltd.（China）
• Covestro AG（Germany）
• International Polymer Engineering（United States）
• Mitsui Chemicals（Japan）

结论和建议

Global Bioresorbable Polymers Market size was valued at USD 3.8 billion in 2023 and is poised to grow from USD 4.19 billion in 2024 to USD 9.18 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The global market for bioresorbable polymers is poised for significant growth, fueled by rising consumer health awareness, enhanced healthcare infrastructure, and an uptick in surgical procedures, with 310 million major surgeries performed annually. These polymers are increasingly utilized in orthopedic implants, such as suture anchors and interference screws, eliminating the need for follow-up surgeries while enhancing patient comfort. Major industry drivers include heightened demand for advanced medical devices, particularly in drug delivery and tissue engineering, alongside the trend towards minimally invasive surgeries. Recent innovations like Ashland's facility expansion in Ireland and Bioretec's FDA-approved RemeOs(TM) trauma screw reflect ongoing advancements that improve biodegradability and biocompatibility. Regulatory support and rising healthcare investments are also propelling the growth of this market, addressing critical clinical needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioresorbable Polymers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioresorbable Polymers Market Segments Analysis

Global Bioresorbable Polymers Market is segmented by Material Type, Application and region. Based on Material Type, the market is segmented into Polylactic Acid, Polyhydroxyalkanoates, Starch Blends, Polybutylene Succinate and Polyhydroxyurethanes. Based on Application, the market is segmented into Packaging, Agriculture, Medical, Consumer Goods, Textile and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioresorbable Polymers Market

The Global Bioresorbable Polymers market is experiencing significant growth due to the increasing demand for environmentally sustainable materials as the world shifts away from traditional plastics. Industries such as packaging, automotive, and agriculture are actively searching for sustainable alternatives that naturally decompose, and bioresorbable polymers present an effective solution. As concerns about plastic waste escalate and regulatory pressures regarding environmental impact intensify, these innovative materials are being adopted for a variety of non-medical applications. This trend underscores the market's potential, as companies seek to align with sustainability goals while addressing the pressing issues associated with plastic pollution.

Restraints in the Global Bioresorbable Polymers Market

The Global Bioresorbable Polymers market faces certain restraints, primarily stemming from the rising preference for minimally invasive surgeries. This trend is attributed to the numerous advantages associated with these procedures, such as shorter hospital stays, quicker recovery times, and reduced pain and bleeding. As a result, there has been a notable shift away from traditional surgical methods, leading to decreased demand for various medical devices that utilize bioresorbable polymers. Laparoscopy, a widely adopted minimally invasive technique, involves creating multiple small incisions in the abdominal or pelvic regions, further contributing to this decline in demand and hindering market growth.

Market Trends of the Global Bioresorbable Polymers Market

The global bioresorbable polymers market is witnessing a significant upward trend, driven largely by the rising demand for medical applications. The unique property of these polymers to naturally degrade within the body without the need for surgical removal makes them particularly attractive for various medical uses, including drug delivery systems, tissue engineering, and surgical sutures. Additionally, their versatility extends to orthopedic implants, cardiovascular devices, and wound healing applications. As healthcare continues to evolve with an aging population and a growing preference for minimally invasive procedures, the market for bioresorbable polymers is poised for substantial growth, reflecting a robust alignment with contemporary healthcare needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Bioresorbable Polymers Market Size by Material Type & CAGR (2025-2032)

• Market Overview
• Polylactic Acid
• Polyhydroxyalkanoates
• Starch Blends
• Polybutylene Succinate
• Polyhydroxyurethanes

Global Bioresorbable Polymers Market Size by Application & CAGR (2025-2032)

• Market Overview
• Packaging
• Agriculture
• Medical
• Consumer Goods
• Textile
• Others

Global Bioresorbable Polymers Market Size & CAGR (2025-2032)

• North America (Material Type, Application)
  • US
  • Canada
• Europe (Material Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Corbion NV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foster Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLS Martin Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ashland Global Holdings Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeus Company LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seqens (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• REVA Medical LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poly-Med Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bezwada Biomedical LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nomisma Healthcare Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BMG Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polysciences Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huizhou Foryou Medical Devices Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Musashino Chemical Laboratory Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Henan Xinghan Biotechnology Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covestro AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Polymer Engineering (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsui Chemicals (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations